Gene · 9156
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the multifaceted role of EXO1 in female-related cancers: implications for prognosis and therapeutic responsiveness. | Front Immunol | 2025 | 40433389 | PubTator, text mining | PubMed |
| CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade. | Science | 2025 | 40403056 | PubTator, text mining | PubMed |
| Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer Therapy. | ACS Chem Biol | 2025 | 40378357 | PubTator, text mining | PubMed |
| Fine-Tuning Homology-Directed Repair (HDR) for Precision Genome Editing: Current Strategies and Future Directions. | Int J Mol Sci | 2025 | 40362308 | PubTator, text mining | PubMed |
| Transcriptome insights into newcastle disease virus-mediated eradication of cholangiocarcinoma cells. | PLoS One | 2025 | 40327606 | PubTator, text mining | PubMed |
| Bioinformatics analysis of intrinsic drivers of immune dysregulation in multiple myeloma to elucidate immune phenotypes and discover prognostic gene signatures. | Sci Rep | 2025 | 40325058 | PubTator, text mining | PubMed |
| EXO1 promotes the meiotic MLH1-MLH3 endonuclease through conserved interactions with MLH1, MSH4 and DNA. | Nat Commun | 2025 | 40319035 | PubTator, text mining | PubMed |
| HEX-1 reduces colitis-driven colorectal cancer via inactivating the prolyl isomerase PIN1 sensitization and remodeling the gut microbiota. | Discov Oncol | 2025 | 40251462 | PubTator, text mining | PubMed |
| Mouse MRE11-RAD50-NBS1 is needed to start and extend meiotic DNA end resection. | Nat Commun | 2025 | 40240347 | PubTator, text mining | PubMed |
| EXO1 as a potential biomarker for prognosis, immune infiltration, and immunotherapy in pan-cancer analysis. | Funct Integr Genomics | 2025 | 40214853 | PubTator, text mining | PubMed |
| Genetic associations of prostate cancer in China: a systematic review. | BMC Cancer | 2025 | 40181298 | PubTator, text mining | PubMed |
| Biochemical Mechanisms of Genetic Recombination and DNA Repair. | Annu Rev Biochem | 2025 | 40153609 | PubTator, text mining | PubMed |
| Mechanisms and regulation of DNA end resection in the maintenance of genome stability. | Nat Rev Mol Cell Biol | 2025 | 40133633 | PubTator, text mining | PubMed |
| MRN-CtIP, EXO1, and DNA2-WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage. | Genes Dev | 2025 | 40127955 | PubTator, text mining | PubMed |
| Comprehensive analysis of intervention and control studies for the computational identification of dengue biomarker genes. | PLoS Negl Trop Dis | 2025 | 40100920 | PubTator, text mining | PubMed |
| Identification of hub genes for the diagnosis and prognosis in triple negative breast cancer using transcriptome and differential methylation integration analysis. | J Cancer | 2025 | 40092695 | PubTator, text mining | PubMed |
| EXO1's pan-cancer roles: diagnostic, prognostic, and immunological analyses through bioinformatics. | Discov Oncol | 2025 | 40074873 | PubTator, text mining | PubMed |
| Targeting FEN1/EXO1 to enhance efficacy of PARP inhibition in triple-negative breast cancer. | Transl Oncol | 2025 | 40054125 | PubTator, text mining | PubMed |
| Targeting the AURKB-MAD2L2 Axis Disrupts the DNA Damage Response and Glycolysis to Inhibit Colorectal Cancer Progression. | Front Biosci (Landmark Ed) | 2025 | 40018943 | PubTator, text mining | PubMed |
| Prime Editing: Mechanistic Insights and DNA Repair Modulation. | Cells | 2025 | 39996750 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9156/papers?page=6